BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11386322)

  • 1. Osteoporosis after organ transplantation.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y
    Lancet; 2001 May; 357(9268):1623. PubMed ID: 11386322
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis after organ transplantation.
    Ponticelli C; Aroldi A
    Lancet; 2001 May; 357(9268):1623. PubMed ID: 11386321
    [No Abstract]   [Full Text] [Related]  

  • 3. Is glucocorticoid-induced osteonecrosis after kidney transplantation related to osteoporosis?
    Ersoy A; Kahvecioglu S; Ersoy C; Akdag I; Yurtsever I; Dilek K
    Nephrol Dial Transplant; 2006 May; 21(5):1452-3. PubMed ID: 16357048
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
    Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
    Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and related risk factors in renal transplant recipients.
    Ahmadpoor P; Reisi S; Makhdoomi K; Ghafari A; Sepehrvand N; Rahimi E
    Transplant Proc; 2009 Sep; 41(7):2820-2. PubMed ID: 19765445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
    Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
    Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin.
    Tolou-Ghamari Z; Palizban AA
    Saudi Med J; 2004 Oct; 25(10):1499-500. PubMed ID: 15494834
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in men.
    Mula-Abed WA
    Saudi Med J; 2005 Oct; 26(10):1663; author reply 1663-4. PubMed ID: 16228084
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteoporosis following heart transplantation and immunosuppressive therapy.
    Löfdahl E; Rådegran G
    Transplant Rev (Orlando); 2017 Oct; 31(4):232-239. PubMed ID: 28865930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.
    Claes K; Meier-Kriesche HU; Schold JD; Vanrenterghem Y; Halloran PF; Ekberg H
    Nephrol Dial Transplant; 2012 Feb; 27(2):850-7. PubMed ID: 21617197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of bone mineral density in renal transplantation recipients.
    Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
    Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities.
    Higgins R; Ramaiyan K; Dasgupta T; Kanji H; Fletcher S; Lam F; Kashi H
    Nephrol Dial Transplant; 2004 Feb; 19(2):444-50. PubMed ID: 14736972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head.
    Shibatani M; Fujioka M; Arai Y; Takahashi K; Ueshima K; Okamoto M; Yoshimura N; Hirota Y; Fukushima W; Kubo T
    Acta Orthop; 2008 Oct; 79(5):631-6. PubMed ID: 18839369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoclonic jerks in a post-transplant patient: is tacrolimus the sole culprit?
    Korzets Z; Kovatz S; Bernheim J; Iraqi A; Shenkman L
    Nephrol Dial Transplant; 2003 Apr; 18(4):843-4. PubMed ID: 12637662
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. Do inhaled steroids increase the risk of osteoporosis?
    Geralyi F; Loven B; Rodriguez JE
    J Fam Pract; 2007 Feb; 56(2):131-6. PubMed ID: 17270120
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone mineral density in the long term after liver transplantation.
    Hamburg SM; Piers DA; van den Berg AP; Slooff MJ; Haagsma EB
    Osteoporos Int; 2000; 11(7):600-6. PubMed ID: 11069194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis after kidney transplantation: preliminary report from a single center.
    Wang HH; Chang PC; Chu SH; Liu KL; Lai PC; Huang JY; Chiang YJ
    Transplant Proc; 2008 Sep; 40(7):2412-3. PubMed ID: 18790251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.